These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34102966)

  • 21. Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities.
    Lal S; Shekher A; Puneet ; Narula AS; Abrahamse H; Gupta SC
    Pharmacol Res; 2021 Jan; 163():105302. PubMed ID: 33246167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabinoids in clinical practice.
    Williamson EM; Evans FJ
    Drugs; 2000 Dec; 60(6):1303-14. PubMed ID: 11152013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
    McCarberg BH; Barkin RL
    Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids.
    Sholler DJ; Huestis MA; Amendolara B; Vandrey R; Cooper ZD
    Pharmacol Biochem Behav; 2020 Dec; 199():173059. PubMed ID: 33086126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoids: from pot to lab.
    Papaseit E; Pérez-Mañá C; Pérez-Acevedo AP; Hladun O; Torres-Moreno MC; Muga R; Torrens M; Farré M
    Int J Med Sci; 2018; 15(12):1286-1295. PubMed ID: 30275754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoid-sensitive receptors in cardiac physiology and ischaemia.
    Puhl SL
    Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118462. PubMed ID: 30890410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA.
    Gamage TF; Farquhar CE; Lefever TW; Marusich JA; Kevin RC; McGregor IS; Wiley JL; Thomas BF
    J Pharmacol Exp Ther; 2018 May; 365(2):437-446. PubMed ID: 29549157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Social Factors and Animal Models of Cannabis Use.
    Hood L
    Int Rev Neurobiol; 2018; 140():171-200. PubMed ID: 30193704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies.
    Millán-Guerrero RO; Isais-Millán S
    Gac Med Mex; 2019; 155(5):471-474. PubMed ID: 32091020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….
    Baron EP
    Headache; 2015 Jun; 55(6):885-916. PubMed ID: 26015168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoids and Pain: New Insights From Old Molecules.
    Vučković S; Srebro D; Vujović KS; Vučetić Č; Prostran M
    Front Pharmacol; 2018; 9():1259. PubMed ID: 30542280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of cannabis in cardiovascular disorders.
    Goyal H; Awad HH; Ghali JK
    J Thorac Dis; 2017 Jul; 9(7):2079-2092. PubMed ID: 28840009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of 3,4-methylenedioxymethamphetamine effects by endocannabinoid system.
    Valverde O; Rodríguez-Árias M
    Curr Pharm Des; 2013; 19(40):7081-91. PubMed ID: 23574444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoids: A Guide for Use in the World of Gastrointestinal Disease.
    Unal E; Anderson B; Helber A; Marks JH
    J Clin Gastroenterol; 2020 Oct; 54(9):769-788. PubMed ID: 31789770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute myocardial infarction, associated with the use of a synthetic adamantyl-cannabinoid: a case report.
    McIlroy G; Ford L; Khan JM
    BMC Pharmacol Toxicol; 2016 Jan; 17():2. PubMed ID: 26772803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review.
    Orsolini L; Chiappini S; Volpe U; Berardis D; Latini R; Papanti GD; Corkery AJM
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31450833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoids: for better and for worse
.
    Thibaut F; Hoehe MR
    Dialogues Clin Neurosci; 2020 Sep; 22(3):201-204. PubMed ID: 33162763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabis, Cannabinoids, and the Endocannabinoid System-Is there Therapeutic Potential for Inflammatory Bowel Disease?
    Ambrose T; Simmons A
    J Crohns Colitis; 2019 Mar; 13(4):525-535. PubMed ID: 30418525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Function of cannabinoids in heart failure].
    Rudź R; Baranowska U; Malinowska B
    Postepy Hig Med Dosw (Online); 2008 May; 62():174-84. PubMed ID: 18464680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.